ANIP — ANI Pharmaceuticals Inc. price, chart and key statistics

Price data

Price

$72.67

YTD price return

-7.94%

YTD total return

-7.94%

Next earnings

Nov 6, 2026

Market cap

1.6B2016-12 704.7M2026-10 1.6B+126.0% over the window

Enterprise value

1.5B

Shares outstanding

21.9M2016-06 11.5M2026-06 21.9M+89.9% over the window

52W low

$69.58

52W high

$97.00

From 52W high

-25.08%

From 52W low

+4.44%

52W range

11%

Volume

Rel volume

0.66×

30D volume

394.1K

30D $ vol

29M

Fundamentals

Sales (ttm)

978.4M2016-06 89.9M2026-06 978.4M+988.3% over the window

Sales/share

$44.642016-06 $7.792026-06 $44.64+473.1% over the window

EPS (ttm)

$5.002016-06 $0.862026-06 $5.00+480.8% over the window

FCF (ttm)

173M2016-06 25.3M2026-06 173M+584.2% over the window

FCF/share

$7.892016-06 $2.192026-06 $7.89+260.3% over the window

Book value/share

$27.252016-06 $14.192026-06 $27.25+92.0% over the window

Net margin

11.07%2016-06 11.0%2026-06 11.1%+0.5% over the window

ROE

18.14%2016-06 6.0%2026-06 18.1%+199.8% over the window

ROA

7.25%2016-06 3.2%2026-06 7.2%+125.4% over the window

Debt / equity

0.47×2016-06 0.712026-06 0.47-34.3% over the window

Current ratio

2.912016-06 3.232026-06 2.91-9.8% over the window

Growth (CAGR, ttm) · 10Y

Sales

+30.93%2025-06-30 → 2026-06-30747.4M → 978.4M (+30.9% total)+34.57%2023-06-30 → 2026-06-30401.4M → 978.4M (+143.8% total)+35.61%2021-06-30 → 2026-06-30213.4M → 978.4M (+358.5% total)+26.97%2016-06-30 → 2026-06-3089.9M → 978.4M (+988.3% total)

Net income

n/an/an/a+27.03%2016-06-30 → 2026-06-309.9M → 108.3M (+993.4% total)

FCF

+37.93%2025-06-30 → 2026-06-30125.4M → 173M (+37.9% total)+77.70%2023-06-30 → 2026-06-3030.8M → 173M (+461.3% total)+84.55%2021-06-30 → 2026-06-308.1M → 173M (+2039.7% total)+21.21%2016-06-30 → 2026-06-3025.3M → 173M (+584.2% total)

Shares

+7.92%2025-06-30 → 2026-06-3020.3M → 21.9M (+7.9% total)+7.07%2023-06-30 → 2026-06-3017.9M → 21.9M (+22.7% total)+12.64%2021-06-30 → 2026-06-3012.1M → 21.9M (+81.3% total)+6.62%2016-06-30 → 2026-06-3011.5M → 21.9M (+89.9% total)

Per-share growth (CAGR, ttm) · 10Y

EPS

n/an/an/a+19.24%2016-06-30 → 2026-06-30$0.86 → $5.00 (+480.8% total)

Sales/share

+21.32%2025-06-30 → 2026-06-30$36.80 → $44.64 (+21.3% total)+25.69%2023-06-30 → 2026-06-30$22.48 → $44.64 (+98.6% total)+20.39%2021-06-30 → 2026-06-30$17.66 → $44.64 (+152.9% total)+19.08%2016-06-30 → 2026-06-30$7.79 → $44.64 (+473.1% total)

FCF/share

+27.81%2025-06-30 → 2026-06-30$6.18 → $7.89 (+27.8% total)+65.97%2023-06-30 → 2026-06-30$1.73 → $7.89 (+357.4% total)+63.83%2021-06-30 → 2026-06-30$0.67 → $7.89 (+1079.9% total)+13.68%2016-06-30 → 2026-06-30$2.19 → $7.89 (+260.3% total)

Book value/share

+26.73%2025-06-30 → 2026-06-30$21.51 → $27.25 (+26.7% total)+5.90%2023-06-30 → 2026-06-30$22.94 → $27.25 (+18.8% total)+11.41%2021-06-30 → 2026-06-30$15.88 → $27.25 (+71.6% total)+6.74%2016-06-30 → 2026-06-30$14.19 → $27.25 (+92.0% total)

Dividend/share

-80.69%2025-06-30 → 2026-06-30$0.08 → $0.02 (-80.7% total)-45.31%2023-06-30 → 2026-06-30$0.10 → $0.02 (-83.7% total)+1.13%2021-12-31 → 2026-06-30$0.02 → $0.02 (+5.2% total)n/a

Price

-23.62%2025-10-20 → 2026-10-20$95.12 → $72.67 (-23.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+8.15%2023-10-20 → 2026-10-20$57.44 → $72.67 (+26.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+13.93%2021-10-20 → 2026-10-20$37.86 → $72.67 (+91.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+0.98%2016-10-19 → 2026-10-20$65.91 → $72.67 (+10.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

-23.62%2025-10-20 → 2026-10-20$95.12 → $72.67 (-23.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+8.15%2023-10-20 → 2026-10-20$57.44 → $72.67 (+26.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+13.93%2021-10-20 → 2026-10-20$37.86 → $72.67 (+91.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+0.98%2016-10-19 → 2026-10-20$65.91 → $72.67 (+10.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

14.5×2016-12 89.322026-10 14.70-83.5% over the window

P/OI (ttm)Price ÷ TTM operating income. Excludes the below-the-line items that make P/E jump — mark-to-market gains, settlements, tax true-ups.

10.6×2016-12 28.132026-10 10.59-62.4% over the window

Fwd P/E

7.1×

P/S (ttm)Market cap ÷ TTM revenue.

1.6×2016-12 6.502026-10 1.63-74.9% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

2.7×2016-12 4.172026-10 2.67-36.1% over the window

P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).

9.2×2016-12 44.572026-10 9.21-79.3% over the window

EV/EBITDA (fy)

6.5×

EV/Sales (ttm)

1.6×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

10.86%2016-09 2.2%2026-06 9.5%+325.0% over the window

Buyback yield (realized, 1y)1 − shares_at(2025-12-31) ÷ shares_at(2024-12-31) = 1 − 22.5M ÷ 21.1M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-6.56%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-6.56%) + dividends paid over that year ($344K) ÷ market_cap_at(2024-12-31) ($1.2B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-6.53%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($22.2M) ÷ today's market cap ($1.6B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

1.40%2016-09 0.4%2026-06 1.2%+245.3% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $22.2M + TTM dividends $344K) ÷ today's market cap ($1.6B). Same caveat as the cash buyback yield.

1.42%2016-09 0.4%2026-06 1.2%+250.7% over the window

Vs own 10Y history

P/E

2nd

P/OI

1st

P/S

2nd

P/B

40th

P/FCF

6th